While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies to steer clear of and a few better alternatives.

Charter (CHTR)

Trailing 12-Month Free Cash Flow Margin: 8.1%

Operating as Spectrum, Charter (NASDAQ: CHTR) is a leading telecommunications company offering cable television, high-speed internet, and voice services across the United States.

Why Is CHTR Risky?

1. Sluggish trends in its internet subscribers suggest customers aren’t adopting its solutions as quickly as the company hoped
2. Stagnant returns on capital show management has failed to improve the company’s business quality

Charter’s stock price of $216.26 implies a valuation ratio of 5.1x forward P/E. Dive into our free research report to see why there are better opportunities than CHTR.

Hillman (HLMN)

Trailing 12-Month Free Cash Flow Margin: 2.3%

Established when Max Hillman purchased a franchise operation, Hillman (NASDAQ: HLMN) designs, manufactures, and sells industrial equipment and systems for various sectors.

Why Does HLMN Worry Us?

1. Muted 2.5% annual revenue growth over the last two years shows its demand lagged behind its industrials peers
2. Low free cash flow margin of 2.6% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
3. Low returns on capital reflect management’s struggle to allocate funds effectively

At $8.32 per share, Hillman trades at 13.8x forward P/E. To fully understand why you should be careful with HLMN, check out our full research report (it’s free).

Envista (NVST)

Trailing 12-Month Free Cash Flow Margin: 8.5%

Uniting more than 30 trusted brands including Nobel Biocare, Ormco, and DEXIS under one corporate umbrella, Envista Holdings (NYSE: NVST) is a global dental products company that provides equipment, consumables, and specialized technologies for dental professionals.

Why Do We Avoid NVST?

1. Muted 2.9% annual revenue growth over the last two years shows its demand lagged behind its healthcare peers
2. Negative returns on capital show that some of its growth strategies have backfired, and its shrinking returns suggest its past profit sources are losing steam
3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

Envista is trading at $25.37 per share, or 17.2x forward P/E. Check out our free in-depth research report to learn more about why NVST doesn’t pass our bar.

Stocks We Like More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.